Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 4/2016

01-04-2016 | Hepatobiliary Tumors

Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?

Authors: J. G. D’Haese, MD, J. Neumann, MD, M. Weniger, MD, S. Pratschke, MD, B. Björnsson, MD, V. Ardiles, MD, W. Chapman, MD, FACS, R. Hernandez-Alejandro, MD, O. Soubrane, MD, R. Robles-Campos, MD, M. Stojanovic, MD, PhD, R. Dalla Valle, MD, A. C. Y. Chan, MD, MBBS, FRCS, FCSHK, FHKAM (Surgery), M. Coenen, PhD, MPH, M. Guba, MD, J. Werner, MD, MBA, E. Schadde, MD, FACS, M. K. Angele, MD, FACS

Published in: Annals of Surgical Oncology | Issue 4/2016

Login to get access

Abstract

Background

Extended liver resections in patients with hepatocellular carcinoma (HCC) are problematic due to hepatitis, fibrosis, and cirrhosis. Associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) has been promoted as a novel method to induce hypertrophy for patients with extensive colorectal liver metastases, but outcomes in HCC have not been well investigated.

Methods

All patients registered in the international ALPPS Registry (www.​alpps.​org) from 2010 to 2015 were studied. Hypertrophy of the future liver remnant, perioperative morbidity and mortality, age, overall survival, and other parameters were compared between patients with HCC and patients with colorectal liver metastases (CRLM).

Results

The study compared 35 patients with HCC and 225 patients with CRLM. The majority of patients undergoing ALPPS for HCC fall into the intermediate-stage category of the Barcelona clinic algorithm. In this study, hypertrophy was rapid and extensive for the HCC patients, albeit lower than for the CRLM patients (47 vs. 76 %; p < 0.002). Hypertrophy showed a linear negative correlation with the degrees of fibrosis. The 90-day mortality for ALPPS used to treat HCC was almost fivefold higher than for CRLM (31 vs. 7 %; p < 0.001). Multivariate analysis showed that patients older than 61 years had a significantly reduced overall survival (p < 0.004).

Conclusion

The ALPPS approach induces a considerable hypertrophic response in HCC patients and allows resection of intermediate-stage HCC, albeit at the cost of a 31 % perioperative mortality rate. The use of ALPPS for HCC remains prohibitive for most patients and should be performed only for a highly selected patient population younger than 60 years with low-grade fibrosis.
Literature
1.
Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver. Ann Surg. 2011;253:656–65.CrossRefPubMed
2.
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14.CrossRefPubMed
3.
de Santibanes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the “ALPPS” approach. Ann Surg. 2012;255:415–7.CrossRefPubMed
4.
Wicherts DA, Miller R, de Haas RJ, et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008;248:994–1005.CrossRefPubMed
5.
Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004;240:1037–49; discussion 1049–51CrossRefPubMedPubMedCentral
6.
Wicherts DA, de Haas RJ, Andreani P, et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg. Feb 2010;97(2):240–250.CrossRefPubMed
7.
Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247:49–57.CrossRefPubMed
8.
Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg. 2014;260:829–36; discussion 836–828CrossRefPubMed
9.
Li J, Girotti P, Konigsrainer I, Ladurner R, Konigsrainer A, Nadalin S. ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure? J Gastrointest Surg. 2013;17:956–61.CrossRefPubMed
10.
Knoefel WT, Gabor I, Rehders A, et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg. 2013;100:388–94.CrossRefPubMed
11.
Torres OJ, Fernandes Ede S, Oliveira CV, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): the Brazilian experience. ABCD Braz Arch Dig Surg. 2013;26:40–3.CrossRef
12.
Chia NH, Lai EC, Lau WY. Associating liver partition and portal vein ligation for a patient with hepatocellular carcinoma with a background of hepatitis B related fibrotic liver. Int J Surg Case Rep. 2014;5:1077–81.CrossRefPubMedPubMedCentral
13.
14.
15.
Chan AC, Pang R, Poon RT. Simplifying the ALPPS procedure by the anterior approach. Ann Surg. 2014;260:e3.CrossRefPubMed
16.
Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002;8:233–40.CrossRefPubMed
17.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRefPubMed
18.
Balzan S, Belghiti J, Farges O, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–8; discussion 828–9.CrossRefPubMedPubMedCentral
19.
Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatol Baltimore Md 1994;19:1513–20.CrossRef
20.
van Lienden KP, van den Esschert JW, de Graaf W, et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013;36:25–34.CrossRefPubMedPubMedCentral
21.
22.
Petrowsky H, Gyori G, de Oliveira M, Lesurtel M, Clavien PA. Is partial ALPPS safer than ALPPS? A single-center experience. Ann Surg. 2015;261:e90–2.CrossRefPubMed
23.
Gall TM, Sodergren MH, Frampton AE, et al. Radiofrequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration. Ann Surg. 2015;261:e45–6.CrossRefPubMed
24.
Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–17; discussion 517–509.CrossRefPubMedPubMedCentral
25.
26.
Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232:665–72.CrossRefPubMedPubMedCentral
27.
Tanaka H, Hirohashi K, Kubo S, Shuto T, Higaki I, Kinoshita H. Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br J Surg. 2000;87:879–82.CrossRefPubMed
28.
Wakabayashi H, Ishimura K, Okano K, et al. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer. 2001;92:2384–90.CrossRefPubMed
29.
Palavecino M, Chun YS, Madoff DC, et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: perioperative outcome and survival. Surgery. 2009;145:399–405.CrossRefPubMed
30.
Seo DD, Lee HC, Jang MK, et al. Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization. Ann Surg Oncol 2007;14:3501–9.CrossRefPubMed
31.
Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–9.CrossRefPubMed
32.
Ismail T, Angrisani L, Gunson BK, et al. Primary hepatic malignancy: the role of liver transplantation. Br J Surg. 1990;77:983–7.CrossRefPubMed
33.
Chan AC, Poon RT, Chan SC, Lo CM. Safety of ALPPS procedure by the anterior approach for hepatocellular carcinoma. Ann Surg. 2015.CrossRef
Metadata
Title
Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?
Authors
J. G. D’Haese, MD
J. Neumann, MD
M. Weniger, MD
S. Pratschke, MD
B. Björnsson, MD
V. Ardiles, MD
W. Chapman, MD, FACS
R. Hernandez-Alejandro, MD
O. Soubrane, MD
R. Robles-Campos, MD
M. Stojanovic, MD, PhD
R. Dalla Valle, MD
A. C. Y. Chan, MD, MBBS, FRCS, FCSHK, FHKAM (Surgery)
M. Coenen, PhD, MPH
M. Guba, MD
J. Werner, MD, MBA
E. Schadde, MD, FACS
M. K. Angele, MD, FACS
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 4/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-5007-0

Other articles of this Issue 4/2016

Annals of Surgical Oncology 4/2016 Go to the issue

Gastrointestinal Oncology

Is All Advanced Gastric Cancer Suitable for Laparoscopy-Assisted Gastrectomy With Extended Lymphadenectomy? A Case–Control Study Using a Propensity Score Method

Hepatobiliary Tumors

Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion

Melanomas

Australian Multicenter Study of Isolated Limb Infusion for Melanoma

Colorectal Cancer

Transanal Total Mesorectal Excision Versus Laparoscopic Surgery for Rectal Cancer Receiving Neoadjuvant Chemoradiation: A Matched Case–Control Study

Gynecologic Oncology

Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus

Melanomas

Excision Margins of Melanoma Make a Difference: New Data Support an Old Paradigm